Corona Remedies has announced its 22nd AGM on July 9, 2026, recommending a ₹10 per share dividend for FY26. Shareholders need to update KYC details for electronic dividend credit.

Corona Remedies Ltd

Corona Remedies Ltd announced its 22nd Annual General Meeting (AGM) scheduled for July 09, 2026, at 11:00 A.M. IST, to be held via Video Conferencing or Other Audio Visual Means.

What just happened

The Board of Directors has recommended a dividend of ₹10 per equity share, with a face value of ₹10 each, for the financial year ended March 31, 2026. This recommendation is subject to shareholder approval at the AGM.

Why this matters

This filing informs shareholders about the upcoming AGM, the dividend proposal, and crucially, the process for receiving it. It emphasizes the need for updated Know Your Customer (KYC) details for electronic dividend credit, ensuring compliance with SEBI guidelines.

The backstory

Corona Remedies is communicating its annual shareholder meeting schedule and a proposed dividend payout. The company is also facilitating access to its Annual Report and AGM notice for shareholders.

What changes now

Shareholders should ensure their PAN, bank account details, nomination preferences, email IDs, and mobile numbers are updated with their Depository Participants to receive the dividend electronically.

Risks to watch

Failure to update KYC details can lead to delays in receiving the proposed dividend, impacting shareholder returns.

Context metrics (time-bound)

• AGM Date: July 09, 2026
• Dividend Recommended: ₹10 per equity share
• Financial Year for Dividend: FY 2025-26 (ended March 31, 2026)
• Board Meeting Date for Recommendation: May 11, 2026

What to track next

Shareholders should await the AGM proceedings and the final approval of the dividend. They must ensure their details are updated with DPs to facilitate timely payment.